Endocrinologic and Metabolic Drugs Advisory Committee

September 26, 2002

Hilton Silver Spring

8727 Colesville Road, Silver Spring, MD

BL 103979, Fabrazyme™ (agalsidase beta) Genzyme Corporation

8:00 Call to Order

Conflict of Interest Statement

Welcome

8:15 Genzyme Presentation

9:45 CBER Presentation

10:45 Open Public Hearing

11:45 Lunch

1:00 Charge to the Committee

1:15 Discussion and Questions

5:00 Adjourn